A Pilot Study in Severe Patients With Takayasu Arteritis.

NCT04300686 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Takayasu Arteritis
Tocilizumab
Adalimumab
Treatment

Interventions

BIOLOGICAL: Tocilizumab
BIOLOGICAL: Adalimumab

Sponsor

Shanghai Zhongshan Hospital